Literature DB >> 15478532

Fulminant Clostridium difficile colitis in a patient with spinal cord injury: case report.

Anil N Bahadursingh1, Parsia A Vagefi, Walter E Longo.   

Abstract

BACKGROUND: In certain patients with Clostridium difficile colitis (CDC), a life-threatening systemic toxicity may develop despite appropriate and timely medical therapy.
DESIGN: Literature search and case report.
FINDINGS: A 39-year-old man with T10 paraplegia presented with a distended, quiet abdomen following recent treatment with antibiotics for pneumonia. Diarrhea was not present. Complete blood counts demonstrated a marked leukocytosis. A CT scan of the abdomen demonstrated a state of diffuse pancolonic inflammation with peritoneal fluid. The patient was taken to the operating room and underwent total abdominal colectomy with oversewing of the rectal stump and end ileostomy for treatment of the fulminant CDC.
CONCLUSION: Patients with spinal cord injury (SCI) often receive antibiotics for infections of the aerodigestive tree and urinary tract and for problems with skin integrity. A heightened awareness of the development of fulminant CDC remains essential in the care of patients with SCI. Any unexplained abdominal illness after recent antibiotic administration should alert the physician to CDC and its potential as a fulminant, potentially fatal illness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15478532     DOI: 10.1080/10790268.2004.11753760

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  2 in total

1.  Follow-up of Pseudomembranous Colitis in Children Using Colonoscopy: A Case Report.

Authors:  Q Zhao; H Yuan; H Hu; M Q Yan
Journal:  West Indian Med J       Date:  2015-04-17       Impact factor: 0.171

2.  Epidemiology of clostridium difficile and vancomycin-resistant Enterococcus colonization in patients on a spinal cord injury unit.

Authors:  Donald M Dumford; Michelle Nerandzic; Shelley Chang; Mary Ann Richmond; Curtis Donskey
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.